drugset / Trial / NCT02759510

Cardiac Output Changes in Cesarean Section

NCT02759510

Phase 0 Unknown 106 enrolled RenJi Hospital
RandomizedParallel-groupDouble-blindTreatment

Summary

Since 2011, phenylephrine was recommended as the preferred drug to maintain blood pressure in obstetric anesthesia.Phenylephrine, an α adrenoceptor agonist, can induce peripheral vasoconstriction to maintain blood pressure, while reflexly decrease heart rate and result in cardiac output (CO) reduction.Norepinephrine acts not only as an α adrenoceptor receptor agonist, but also as a weaker β adrenergic receptor agonist. It can elevate blood pressure the same asphenylephrine, meanwhile produce positive inotropic effect including increasing heart rate.Thus, the administration of norepinephrine can maintain blood pressue and avoid the decline of CO. The purpose of this study is to evaluate the effect of norepinephrine and phenylephrine on maternal CO in cesarean section by transesophageal echocardiography.

Timeline

Start
2016-06
Primary completion
2016-06
Completion
2017-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Norepinephrine Other / unclassified 2 ug Intravenous
Comparator Phenylephrine Small molecule 40 ug Intravenous

Indications